Amir A. Borhani
- Surgery top 10%
- Hepatology top 2%
- Epidemiology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Oncology top 10%
- Co-authors
- Alessandro FurlanKeyanoosh HosseinzadehMatthew T. HellerMitchell TublinRoberto CannellaJames V. FerrisOmar AlmusaAllan Tsung
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (42 papers)Liver Disease Diagnosis and Treatment (37 papers)Liver Disease and Transplantation (25 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaGastroenterology
- Partner nations
- United StatesItalyIran
In The Last Decade
Amir A. Borhani
98 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 93
- Surgery 521
- Hepatology 497
- Epidemiology 424
- Radiology, Nuclear Medicine and Imaging 400
- Oncology 378
Countries citing papers authored by Amir A. Borhani
This map shows the geographic impact of Amir A. Borhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir A. Borhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir A. Borhani more than expected).
Fields of papers citing papers by Amir A. Borhani
This network shows the impact of papers produced by Amir A. Borhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir A. Borhani. The network helps show where Amir A. Borhani may publish in the future.
Co-authorship network of co-authors of Amir A. Borhani
This figure shows the co-authorship network connecting the top 25 collaborators of Amir A. Borhani. A scholar is included among the top collaborators of Amir A. Borhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir A. Borhani. Amir A. Borhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 5 | |
| 5 | 12 | |
| 6 | 4 | |
| 7 | 0 | |
| 8 | 9 | |
| 9 | 5 | |
| 10 | 11 | |
| 11 | 1 | |
| 12 | 14 | |
| 13 | 15 | |
| 14 | 3 | |
| 15 | 7 | |
| 16 | 3 | |
| 17 | 3 | |
| 18 | 1 | |
| 19 | 14 | |
| 20 | 8 |
About Amir A. Borhani
Amir A. Borhani is a scholar working on Hepatology, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 111 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (42 papers), Liver Disease Diagnosis and Treatment (37 papers) and Liver Disease and Transplantation (25 papers). The work is most often cited by research in Hepatology (497 citations), Radiology, Nuclear Medicine and Imaging (400 citations) and Oncology (378 citations). Amir A. Borhani has collaborated with scholars based in United States, Italy and Iran. Frequent co-authors include Alessandro Furlan, Keyanoosh Hosseinzadeh, Matthew T. Heller, Mitchell Tublin, Roberto Cannella, James V. Ferris, Omar Almusa, Allan Tsung, Michael A. Nalesnik and Roberta Catania. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.